Compounds > rabeprazole
Page last updated: 2024-08-16

rabeprazole and tenatoprazole

rabeprazole has been researched along with tenatoprazole in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Bi, Y; Kuberan, B; Might, M; Vankayalapati, H1
Beghyn, T; Bosc, D; Charton, J; Deprez, B; Deprez-Poulain, R; Guillaume, V; Herledan, A; Hermant, P; Landry, V; Leroux, F; Liang, W; Pottiez, V; Sheng, L; Tang, WJ; Urata, S; Warenghem, S1
Hofmann, U; Nies, AT; Resch, C; Rius, M; Schaeffeler, E; Schwab, M1
Arnaud, B; Arnoult, C; Escoffier, J; Hograindleur, JP; Kaba, M; Le Blévec, E; Martinez, G; Nef, S; Ray, PF; Stévant, I1
Bhaduri-McIntosh, S; Bleck, CKE; Carter, C; Mannemuddhu, SS; Tjandra, N; Xu, H1

Other Studies

5 other study(ies) available for rabeprazole and tenatoprazole

ArticleYear
Repurposing of Proton Pump Inhibitors as first identified small molecule inhibitors of endo-β-N-acetylglucosaminidase (ENGase) for the treatment of NGLY1 deficiency, a rare genetic disease.
    Bioorganic & medicinal chemistry letters, 2017, 07-01, Volume: 27, Issue:13

    Topics: Dose-Response Relationship, Drug; Enzyme Inhibitors; Genetic Diseases, Inborn; Humans; Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase; Molecular Structure; Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase; Proton Pump Inhibitors; Proton Pumps; Rabeprazole; Small Molecule Libraries; Structure-Activity Relationship

2017
Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening.
    European journal of medicinal chemistry, 2019, Oct-01, Volume: 179

    Topics: Azoles; Biocatalysis; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Repositioning; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Insulysin; Isoindoles; Molecular Structure; Organoselenium Compounds; Structure-Activity Relationship

2019
Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).
    PloS one, 2011, Volume: 6, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Biological Transport; Cell Line; Humans; Imidazoles; Immunoblotting; Inhibitory Concentration 50; Lansoprazole; Metformin; Omeprazole; Organic Cation Transport Proteins; Organic Cation Transporter 1; Organic Cation Transporter 2; Protein Binding; Proton Pump Inhibitors; Rabeprazole

2011
Pantoprazole, a proton-pump inhibitor, impairs human sperm motility and capacitation in vitro.
    Andrology, 2020, Volume: 8, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Fertilization; Humans; Lansoprazole; Male; Membrane Potentials; Middle Aged; Omeprazole; Pantoprazole; Phosphorylation; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Semen Analysis; Sperm Capacitation; Sperm Maturation; Sperm Motility; Spermatozoa; Young Adult

2020
Prazoles Targeting Tsg101 Inhibit Release of Epstein-Barr Virus following Reactivation from Latency.
    Journal of virology, 2021, 06-10, Volume: 95, Issue:13

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; A549 Cells; Antiviral Agents; Cell Line, Tumor; DNA-Binding Proteins; Endosomal Sorting Complexes Required for Transport; Epstein-Barr Virus Infections; HEK293 Cells; Herpesvirus 4, Human; Humans; Proton Pump Inhibitors; Rabeprazole; Transcription Factors; Viral Load; Virus Activation; Virus Latency; Virus Release; Virus Replication

2021